Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells

Cancer Letters
Radosław JanuchowskiPaweł P Jagodzinski

Abstract

Histone deacetylase inhibitor Trichostatin A (TSA), alone, is able to activate the transcription of DNA methylation-mediated silenced genes in human cancer cells. Increase in expression and half-life of the DNA methyltransferase DNMT1 has been found in carcinomas of the colon, lung, liver, prostate, and breast cancer. This overexpression of DNMT1 is responsible for hypermethylation of regulatory sequences of many genes involved in tumorigenesis. Using quantitative real-time PCR and Western blot analysis, we found that TSA down-regulate DNMT1 mRNA and protein expression in Jurkat T leukemia cells clone E6-1. We also observed that TSA decreased DNMT1 mRNA stability and reduced this transcript half-life from approximately 7 to 2h. We also found that protein biosynthesis is needed for posttranscriptional regulation of DNMT1 mRNA, which suggests the involvement of an RNase and/or mRNA stabilization protein entity in DNMT1 transcript stabilization. Our findings suggest that TSA not only alters histone acetylation, but also may affect DNA methylation.

References

Jul 12, 2002·Mental Retardation and Developmental Disabilities Research Reviews·Helle Faerk Jørgensen, Adrian Bird
Sep 7, 2002·Molecular and Cellular Biology·Ryan A IrvineChih-Lin Hsieh
Nov 15, 2002·The New England Journal of Medicine·William C Hahn, Robert A Weinberg
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Mélanie PrimeauRichard L Momparler
May 29, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Wei-Guo Zhu, Gregory A Otterson
Sep 27, 2003·Annals of Hematology·C S ChimY L Kwong
Mar 10, 2005·The Journal of Biological Chemistry·Agoston T AgostonWilliam G Nelson
Apr 1, 2005·Nature·Sarah Kimmins, Paolo Sassone-Corsi
May 4, 2005·Cancer Research·Michael T McCabeMark L Day

❮ Previous
Next ❯

Citations

Oct 21, 2010·Human Reproduction Update·Ewka C M NelissenJohannes L H Evers
May 25, 2010·Nucleic Acids Research·Hans-Jörg WarnatzMarie-Laure Yaspo
Jul 28, 2011·Molecular and Cellular Biology·Mohsen Karimi ArzenaniTomas J Ekström
Jan 17, 2012·Blood·Tatiana AkimovaWayne W Hancock
May 6, 2010·PLoS Genetics·Reinhard BrunmeirChristian Seiser
May 5, 2011·World Journal of Biological Chemistry·Matthias Ocker
Feb 15, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Raul A Chavez ValenciaJustine A Ellis
May 6, 2009·Stem Cells·Dong Wook HanHans R Schöler
Dec 26, 2015·International Journal of Molecular Sciences·Agnieszka Kaufman-SzymczykKrystyna Fabianowska-Majewska
Jan 20, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H Drzewiecka, P P Jagodzinski
Oct 18, 2011·Experimental Cell Research·Pei-Yao LiuShih-Ming Huang
Nov 11, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Szymon Debicki, Paweł P Jagodzinski
Sep 23, 2008·The International Journal of Biochemistry & Cell Biology·Stephanie SpangeOliver H Krämer
Jul 8, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M W Łuczak, P P Jagodziński
Dec 21, 2006·International Immunopharmacology·Radosław Januchowski, Paweł P Jagodzinski
Oct 28, 2008·Brain Research·Ying-Chih LinJane L Ko
Jun 19, 2013·Toxicology Letters·Yangbo LiuBo Zhang
Dec 7, 2010·Biochemical and Biophysical Research Communications·Ai-niu MaYong-xiang Wang
May 10, 2017·British Journal of Haematology·Xiaokun ZhangJianmin Luo
Apr 12, 2008·International Journal of Cancer. Journal International Du Cancer·Ken KawamotoRajvir Dahiya
Nov 2, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Donghong ZhangYi Zhu
Oct 31, 2007·Arthritis and Rheumatism·Lars C HuberSteffen Gay
Jun 18, 2010·Expert Review of Anticancer Therapy·Brahma N SinghShi-Wen Jiang
Jul 29, 2019·Cellular and Molecular Life Sciences : CMLS·Shuangbo KongJinhua Lu
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David S Schrump

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.